New heart ablation waveforms aim to tame atrial fibrillation

NCT ID NCT07444320

Recruiting now Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 4 times

Summary

This study tests new waveforms delivered by the FARAPULSE PFA system to treat atrial fibrillation, a common heart rhythm problem. About 200 adults with paroxysmal or persistent atrial fibrillation will receive the procedure. The goal is to see if these new waveforms are safe and can effectively isolate the pulmonary veins and posterior wall of the heart to restore normal rhythm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FARAPULSE Pulsed Field Ablation (PFA) System (device)
What this could lead to: If successful, this could offer a safer, more precise way to treat atrial fibrillation, potentially reducing complications and improving outcomes.
What could go wrong: This is an early feasibility study with only 200 participants, so results may not apply to everyone. There are risks of procedure-related complications like bleeding or heart rhythm issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation paroxysmal atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAROXYSMAL ATRIAL FIBRILLATION PERSISTENT ATRIAL FIBRILLATION

Contacts and locations

Locations

Klinicki Bolnicki Centar Split
RECRUITING

Split, 21 000, Croatia
Na Homolce Hospital
RECRUITING

Prague, 15030, Czechia
Queen Mary Hospital
NOT_YET_RECRUITING

Hong Kong, Hong Kong
Taipei Veterans General Hospital-Hospital
NOT_YET_RECRUITING

Taipei, 1127, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.